Literature DB >> 31264211

Psychological therapies for the prevention of migraine in adults.

Louise Sharpe1, Joanne Dudeney, Amanda C de C Williams, Michael Nicholas, Ingrid McPhee, Andrew Baillie, Miriam Welgampola, Brian McGuire.   

Abstract

BACKGROUND: Migraine is a common neurological problem associated with the highest burden amongst neurological conditions in terms of years lived with disability. Medications can be used as prophylaxis or rescue medicines, but are costly and not always effective. A range of psychological interventions have been developed to manage migraine.
OBJECTIVES: The objective was to evaluate the efficacy and adverse events of psychological therapies for the prevention of migraine in adults. SEARCH
METHODS: We searched CENTRAL, MEDLINE, Embase, PsycINFO and CINAHL from their inception until July 2018, and trials registries in the UK, USA, Australia and New Zealand for randomised controlled trials of any psychological intervention for adults with migraine. SELECTION CRITERIA: We included randomised controlled trials (RCTs) of a psychological therapy for people with chronic or episodic migraine, with or without aura. Interventions could be compared to another active treatment (psychological or medical), an attention-placebo (e.g. supportive counselling) or other placebo, routine care, or waiting-list control. We excluded studies where fewer than 15 participants completed each arm. DATA COLLECTION AND ANALYSIS: We extracted study characteristics and outcome data at post-treatment and the longest available follow-up. We analysed intervention versus control comparisons for the primary outcome of migraine frequency. We measured migraine frequency using days with migraines or number of migraine attacks measured in the four weeks after treatment. In addition, we analysed the following secondary outcomes: responder rate (the proportion of participants with a 50% reduction in migraine frequency between the four weeks prior to and the four weeks after treatment); migraine intensity; migraine duration; migraine medication usage; mood; quality of life; migraine-related disability; and proportion of participants reporting adverse events during the treatment. We included these variables, where available, at follow-up, the timing of which varied between the studies. We used the GRADE approach to judge the quality of the evidence. MAIN
RESULTS: We found 21 RCTs including 2482 participants with migraine, and we extracted meta-analytic data from 14 of these studies. The majority of studies recruited participants through advertisements, included participants with migraine according to the International Classification of Headache Disorders (ICHD) criteria and those with and without aura. Most intervention arms were a form of behavioural or cognitive-behavioural therapy. The majority of comparator arms were no treatment, routine care or waiting list. Interventions varied from one 20-minute session to 14 hours of intervention. No study had unequivocally low risk of bias; all had at least one domain at high risk of bias, and 20 had two to five domains at high risk. Reporting of randomisation procedures and allocation concealment were at high or unclear risk of bias. We downgraded the quality of evidence for outcomes to very low, due to very serious limitations in study quality and imprecision. Reporting in trials was poor; we found no preregistrations stipulating the outcomes, or demonstrating equivalent expectations between groups. Few studies reported our outcomes of interest, most only reported outcomes post treatment; follow-up data were sparse.Post-treatment effectsWe found no evidence of an effect of psychological interventions for migraine frequency in number of migraines or days with migraine (standardised mean difference (SMD) -0.02, 95% confidence interval (CI) -0.17 to 0.13; 4 studies, 681 participants; very low-quality evidence).The responder rate (proportion of participants with migraine frequency reduction of more than 50%) was greater for those who received a psychological intervention compared to control: 101/186 participants (54%) with psychological therapy; 37/152 participants (24%) with control (risk ratio (RR) 2.21, 95% CI 1.63 to 2.98; 4 studies, 338 participants; very low-quality evidence). We found no effect of psychological therapies on migraine intensity (SMD -0.13, 95% CI -0.28 to 0.02; 4 studies, 685 participants). There were no data for migraine duration (hours of migraine per day). There was no effect on migraine medication usage (SMD -0.06, 95% CI -0.35 to 0.24; 2 studies, 483 participants), mood (mean difference (MD) 0.08, 95% CI -0.33 to 0.49; 4 studies, 432 participants), quality of life (SMD -0.02, 95% CI -0.30 to 0.26; 4 studies, 565 participants), or migraine-related disability (SMD -0.67, 95% CI -1.34 to 0.00; 6 studies, 952 participants). The proportion of participants reporting adverse events did not differ between those receiving psychological treatment (9/107; 8%) and control (30/101; 30%) (RR 0.16, 95% CI 0.00 to 7.85; 2 studies, 208 participants). Only two studies reported adverse events and so we were unable to draw any conclusions.We rated evidence from all studies as very low quality.Follow-upOnly four studies reported any follow-up data. Follow-ups ranged from four months following intervention to 11 months following intervention. There was no evidence of an effect on any outcomes at follow-up (very low-quality evidence). AUTHORS'
CONCLUSIONS: This review identified 21 studies of psychological interventions for the management of migraine. We did not find evidence that psychological interventions affected migraine frequency, a result based on four studies of primarily brief treatments. Those who received psychological interventions were twice as likely to be classified as responders in the short term, but this was based on very low-quality evidence and there was no evidence of an effect of psychological intervention compared to control at follow-up. There was no evidence of an effect of psychological interventions on medication usage, mood, migraine-related disability or quality of life. There was no evidence of an effect of psychological interventions on migraine frequency in the short-term or long-term. In terms of adverse events, we were unable to draw conclusions as there was insufficient evidence. High and unclear risk of bias in study design and reporting, small numbers of participants, performance and detection bias meant that we rated all evidence as very low quality. Therefore, we conclude that there is an absence of high-quality evidence to determine whether psychological interventions are effective in managing migraine in adults and we are uncertain whether there is any difference between psychological therapies and controls.

Entities:  

Mesh:

Year:  2019        PMID: 31264211      PMCID: PMC6603250          DOI: 10.1002/14651858.CD012295.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  100 in total

1.  Guidelines for controlled trials of drugs in migraine: second edition.

Authors:  P Tfelt-Hansen; G Block; C Dahlöf; H C Diener; M D Ferrari; P J Goadsby; V Guidetti; B Jones; R B Lipton; H Massiou; C Meinert; G Sandrini; T Steiner; P B Winter
Journal:  Cephalalgia       Date:  2000-11       Impact factor: 6.292

2.  Migraine and hypnotherapy.

Authors:  J A Anderson; M A Basker; R Dalton
Journal:  Int J Clin Exp Hypn       Date:  1975-01

3.  The International Classification of Headache Disorders, 3rd edition (beta version).

Authors: 
Journal:  Cephalalgia       Date:  2013-07       Impact factor: 6.292

4.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

5.  Psychophysiological reactivity in migraine following biofeedback.

Authors:  C Reading
Journal:  Headache       Date:  1984-03       Impact factor: 5.887

6.  Relaxation for the treatment of headache. Controlled evaluation of two group programs.

Authors:  D A Williamson; J E Monguillot; M P Jarrell; R A Cohen; J M Pratt; D C Blouin
Journal:  Behav Modif       Date:  1984-07

7.  Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years.

Authors:  Licia Grazzi; Frank Andrasik; Domenico D'Amico; Massimo Leone; Susanna Usai; Steven J Kass; Gennaro Bussone
Journal:  Headache       Date:  2002-06       Impact factor: 5.887

8.  Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: An exploratory randomized controlled trial.

Authors:  Paul R Martin; Rachele Aiello; Kathryn Gilson; Graham Meadows; Jeannette Milgrom; John Reece
Journal:  Behav Res Ther       Date:  2015-07-21

Review 9.  Behavioral management of headache triggers: Avoidance of triggers is an inadequate strategy.

Authors:  Paul R Martin; Colin MacLeod
Journal:  Clin Psychol Rev       Date:  2009-06-07

10.  The Effectiveness of Mindfulness-Based Stress Reduction on Perceived Pain Intensity and Quality of Life in Patients With Chronic Headache.

Authors:  Nour Mohammad Bakhshani; Ahmadreza Amirani; Hamed Amirifard; Mahnaz Shahrakipoor
Journal:  Glob J Health Sci       Date:  2015-08-06
View more
  7 in total

Review 1.  Nutraceuticals and Behavioral Therapy for Headache.

Authors:  Rebecca Barmherzig; Thilinie Rajapakse
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-10       Impact factor: 5.081

2.  Enhanced mindfulness-based stress reduction in episodic migraine-effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial.

Authors:  Shana A B Burrowes; Olga Goloubeva; Kristen Stafford; Patrick F McArdle; Madhav Goyal; B Lee Peterlin; Jennifer A Haythornthwaite; David A Seminowicz
Journal:  Pain       Date:  2022-03-01       Impact factor: 7.926

3.  Efficacy of Cognitive-Behavioral Therapy for the Prophylaxis of Migraine in Adults: A Three-Armed Randomized Controlled Trial.

Authors:  Timo Klan; Charly Gaul; Eva Liesering-Latta; Bernhard Both; Isabella Held; Severin Hennemann; Michael Witthöft
Journal:  Front Neurol       Date:  2022-04-28       Impact factor: 4.086

Review 4.  Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment.

Authors:  Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman; Lakshya Motwani
Journal:  Cureus       Date:  2022-06-16

5.  Psychological therapies for the management of chronic pain (excluding headache) in adults.

Authors:  Amanda C de C Williams; Emma Fisher; Leslie Hearn; Christopher Eccleston
Journal:  Cochrane Database Syst Rev       Date:  2020-08-12

6.  Treatment Realities of Headache Disorders in Rural Germany by the Example of the Region of Western Pomerania.

Authors:  Anne Thiele; Sebastian Strauß; Anselm Angermaier; Lara Klehr; Luise Bartsch; Martin Kronenbuerger; Sein Schmidt; Robert Fleischmann
Journal:  Brain Sci       Date:  2021-06-24

7.  Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial.

Authors:  Judith A Pijpers; Dennis A Kies; Erik W van Zwet; Frits R Rosendaal; Gisela M Terwindt
Journal:  Eur J Neurol       Date:  2022-02-10       Impact factor: 6.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.